Glipizide

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Jump to: navigation, search

Synonyms / Brand Names: Glipizida, Glipizidum, Glydiazinamide, Aldiab, Digrin, Dipazide, Glibenese, Glibetin, Glican, Glide, Glidiab, Glipid, Glipizide Extended-Release Tablets, Gluco-Rite, Glucolip, Glucotrol, Glucotrol XL, Glucozide, Glupitel, Glupizide, Glyde, Melizide, Metaglip, Mindiab, Minidab, Minidiab, Minodiab, Napizide, Ozidia, Sucrazide

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884

Dosing and Administration

The usual starting dose of GLUCOTROL XL as initial therapy is 5 mg per day, given with breakfast. Those patients who may be more sensitive to hypoglycemic drugs may be started at a lower dose.

Dosage adjustment should be based on laboratory measures of glycemic control. While fasting blood-glucose levels generally reach steady-state following initiation or change in GLUCOTROL XL dosage, a single fasting glucose determination may not accurately reflect the response to therapy. In most cases, hemoglobin A1C level measured at three month intervals is the preferred means of monitoring response to therapy.

For more information on dosing please refer to Instructions for administration



FDA Package Insert Resources
Indications, Contraindications, Side Effects, Drug Interactions, etc.

Calculate Creatine Clearance
On line calculator of your patients Cr Cl by a variety of formulas.

Convert pounds to Kilograms
On line calculator of your patients weight in pounds to Kg for dosing estimates.

Publication Resources
Recent articles, WikiDoc State of the Art Review, Textbook Information

Trial Resources
Ongoing Trials, Trial Results

Guidelines & Evidence Based Medicine Resources
US National Guidelines, Cochrane Collaboration, etc.

Media Resources
Slides, Video, Images, MP3, Podcasts, etc.

Patient Resources
Discussion Groups, Handouts, Blogs, News, etc.

International Resources
en Español






FDA Package Insert Resources

Indications

Contraindications

Side Effects

Drug Interactions

Precautions

Overdose

Instructions for Administration

How Supplied

Pharmacokinetics and Molecular Data

FDA label

FDA on Glipizide

Return to top

Publication Resources

Most Recent Articles on Glipizide

Review Articles on Glipizide

Articles on Glipizide in N Eng J Med, Lancet, BMJ

WikiDoc State of the Art Review

Textbook Information on Glipizide

Return to top

Trial Resources

Ongoing Trials with Glipizide at Clinical Trials.gov

Trial Results with Glipizide

Return to top

Guidelines & Evidence Based Medicine Resources

US National Guidelines Clearinghouse on Glipizide

Cochrane Collaboration on Glipizide

Cost Effectiveness of Glipizide

Return to top

Media Resources

Powerpoint Slides on Glipizide

Images of Glipizide

Podcasts & MP3s on Glipizide

Videos on Glipizide

Return to top

Patient Resources

Patient Information from National Library of Medicine

Patient Resources on Glipizide

Discussion Groups on Glipizide

Patient Handouts on Glipizide

Blogs on Glipizide

Glipizide in the News

Glipizide in the Marketplace

Return to top

International Resources

Glipizide en Español

Return to top


The content of this page is taken from the FDA package insert for this drug and should not be edited.

Personal tools